Frontotemporal dementia and/or amyotrophic lateral sclerosis-3
FTDALS3

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 4 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Dementia nervous 100 % 24042580 2020-01-25
Cerebral atrophy nervous 100 % 24042580 2020-01-25
Behavioural disinhibition nervous 75 % 24042580 2020-01-25
Apathy nervous 50 % 24042580 2020-01-25
Bulimia nervous 25 % 24042580 2020-01-25
Echolalia nervous 25 % 24042580 2020-01-25
Palilalia nervous 25 % 24042580 2020-01-25
Rigidity nervous 25 % 24042580 2020-01-25
Basal ganglia calcifications nervous 25 % 24042580 2020-01-25
Motor neuron degeneration nervous 25 % 24042580 2020-01-25
Dysarthria nervous 25 % 24042580 2020-01-25
Hyperactive reflexes nervous 25 % 24042580 2020-01-25
Fasciculations nervous 25 % 24042580 2020-01-25
Muscle atrophy nervous 25 % 24042580 2020-01-25



List of references:


SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.
Isabelle Le Ber, Agnès Camuzat, Rita Guerreiro, Kawtar Bouya-Ahmed, Jose Bras, Gael Nicolas, Audrey Gabelle, Mira Didic, Anne De Septenville, Stéphanie Millecamps, Timothée Lenglet, Morwena Latouche, Edor Kabashi, Dominique Campion, Didier Hannequin, John Hardy, Alexis Brice, ,



JAMA neurology - Nov 2013